The Meakins-Christie Laboratories is one of the premiere centres for pulmonary research in the world and Canada. The Meakins was founded in 1972 by Dr. Peter Macklem. It comprises the largest group of investigators within the Translational Research in Respiratory Diseases Program at the RI-MUHC. Our overall mission is to better understand the pathobiology of respiratory disorders. Our goal is to drive innovations in respiratory disease prevention, diagnosis, and therapy. As a result, our research is focused around four main themes: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
In the News
Five CIHR Project Grants awarded!
Congratulations to all Meakins and RECRU members who were funded in the Fall 2019 Project Grant Competition!
Grant to investigate HSCs & innate immunity
Maziar Divangahi receives funding from the Bill & Melinda Gates Foundation.
Epigenetics of vaping project funded by QRHN
Carolyn Baglole receives QRHN funding for project entitled “Evaluate the Epigenetic Lung Effects of Vaping”
OBVIA funds innovative AI program
Faiz Ahmad Khan received funding from OBVIA to evaluate AI based tools for diagnosing tuberculosis
Jean Bourbeau named distinguished CHEST Educator
Dr. Jean Bourbeau was honoured as a 2019 Distinguished CHEST Educator
McGill Research Centre for Cannabis holds Inaugural Science and Research Day
The new McGill Research Centre for Cannabis held its inaugural Science and Research Day on Thursday, October 17, 2019, at the RI-MUHC
Upcoming Events
Lipid Biology in Respiratory Diseases
Preliminary Agenda Available! Lipid Biology in Respiratory Diseases – Meakins Workshop set for March 28, 2020
